200 related articles for article (PubMed ID: 11376868)
1. Structural characterization of erythroid and megakaryocytic differentiation in Friend erythroleukemia cells.
Hyman T; Rothmann C; Heller A; Malik Z; Salzberg S
Exp Hematol; 2001 May; 29(5):563-71. PubMed ID: 11376868
[TBL] [Abstract][Full Text] [Related]
2. Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells.
Richon VM; Rifkind RA; Marks PA
Cell Growth Differ; 1992 Jul; 3(7):413-20. PubMed ID: 1419904
[TBL] [Abstract][Full Text] [Related]
3. Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells.
Kiyokawa H; Richon VM; Rifkind RA; Marks PA
Mol Cell Biol; 1994 Nov; 14(11):7195-203. PubMed ID: 7935434
[TBL] [Abstract][Full Text] [Related]
4. Effects of activin A/erythroid differentiation factor on erythroid and megakaryocytic differentiations of mouse erythroleukemia (Friend) cells: evidence for two distinct modes of cell response.
Okafuji K; Kaku K; Seguchi M; Tanaka H; Azuno Y; Kaneko T
Exp Hematol; 1995 Mar; 23(3):210-6. PubMed ID: 7875239
[TBL] [Abstract][Full Text] [Related]
5. Identification and conditions for selective expression of megakaryocytic markers in Friend erythroleukemia cells.
Paoletti F; Vannucchi AM; Mocali A; Caporale R; Burstein SA
Blood; 1995 Oct; 86(7):2624-31. PubMed ID: 7670106
[TBL] [Abstract][Full Text] [Related]
6. Induced differentiation, the cell cycle, and the treatment of cancer.
Rifkind RA; Richon VM; Marks PA
Pharmacol Ther; 1996; 69(2):97-102. PubMed ID: 8984510
[TBL] [Abstract][Full Text] [Related]
7. Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation.
Baldassarre G; Barone MV; Belletti B; Sandomenico C; Bruni P; Spiezia S; Boccia A; Vento MT; Romano A; Pepe S; Fusco A; Viglietto G
Oncogene; 1999 Nov; 18(46):6241-51. PubMed ID: 10597222
[TBL] [Abstract][Full Text] [Related]
8. Stem cell factor inhibits erythroid differentiation by modulating the activity of G1-cyclin-dependent kinase complexes: a role for p27 in erythroid differentiation coupled G1 arrest.
Tamir A; Petrocelli T; Stetler K; Chu W; Howard J; Croix BS; Slingerland J; Ben-David Y
Cell Growth Differ; 2000 May; 11(5):269-77. PubMed ID: 10845428
[TBL] [Abstract][Full Text] [Related]
9. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization.
Hafid-Medheb K; Poindessous-Jazat V; Augery-Bourget Y; Hanania N; Robert-Lézénès J
Cell Death Differ; 1999 Feb; 6(2):166-74. PubMed ID: 10200563
[TBL] [Abstract][Full Text] [Related]
10. Hexamethylenebisacetamide-induced erythroleukemia cell differentiation involves modulation of events required for cell cycle progression through G1.
Kiyokawa H; Richon VM; Venta-Perez G; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6746-50. PubMed ID: 8341693
[TBL] [Abstract][Full Text] [Related]
11. Constitutive expression of a megakaryocytic functional property by murine erythroleukemia (Friend) cells: the incorporation of serotonin.
Vannucchi AM; Grossi A; Paoletti F; Rafanelli D; Bacci P; Ferrini PR
Exp Hematol; 1992 Dec; 20(11):1296-301. PubMed ID: 1493858
[TBL] [Abstract][Full Text] [Related]
12. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state.
Chen J; Kremer CS; Bender TP
Oncogene; 2002 Mar; 21(12):1859-69. PubMed ID: 11896618
[TBL] [Abstract][Full Text] [Related]
13. A common megakaryocytic and erythrocytic precursor in murine erythroleukemia (Friend) cells?
Vannucchi AM; Paoletti F; Grossi A
Exp Hematol; 1994 Feb; 22(2):110-1. PubMed ID: 8299731
[No Abstract] [Full Text] [Related]
14. NF-E2p18/mafK is required in DMSO-induced differentiation of Friend erythroleukemia cells by enhancing NF-E2 activity.
Francastel C; Poindessous-Jazat V; Augery-Bourget Y; Robert-Lézénès J
Leukemia; 1997 Feb; 11(2):273-80. PubMed ID: 9009092
[TBL] [Abstract][Full Text] [Related]
15. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ
Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953
[TBL] [Abstract][Full Text] [Related]
16. C-Jun modulates apoptosis but not terminal cell differentiation in murine erythroleukemia cells.
Poindessous-Jazat V; Augery-Bourget Y; Robert-Lézénès J
Leukemia; 2002 Feb; 16(2):233-43. PubMed ID: 11840290
[TBL] [Abstract][Full Text] [Related]
17. A phenylacetate derivative, SCK6, inhibits cell proliferation via G1 cell cycle arrest and apoptosis.
Chan HC; Kuo SC; Huang LJ; Liu CH; Hsu SL
Eur J Pharmacol; 2003 Apr; 467(1-3):31-9. PubMed ID: 12706452
[TBL] [Abstract][Full Text] [Related]
18. Interferon-independent activation of (2'-5') oligoadenylate synthetase in Friend erythroleukemia cell variants exposed to HMBA.
Salzberg S; Heller A; Zou JP; Collart FR; Huberman E
J Cell Sci; 1996 Jun; 109 ( Pt 6)():1517-26. PubMed ID: 8799838
[TBL] [Abstract][Full Text] [Related]
19. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
[TBL] [Abstract][Full Text] [Related]
20. Proliferation is required for induction of terminal differentiation of Friend erythroleukemia cells.
Spriggs LL; Hill SM; Jeter JR
Biochem Cell Biol; 1992 Jul; 70(7):555-64. PubMed ID: 1449723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
